Speaker Profile
Ph.D., Assocaite Professor and Reader in Cancer Biomarker and Epigenetics and Director of the Molecular Epidemiology Laboratory, Wolfson Inst. of Population Health
Biography
As the Director of the Molecular Epidemiology Laboratory, the lead of the MEL research team holds a PhD in genetics from Queen Mary and a Masters from University Pierre et Marie Curie, Paris. With a strong background in functional genomics, this individual also brings commercial insights from a role as Head of Genetics at GeneU, a startup. At Imperial College London, the lead spun out GeneU, focusing on genomics data for skin cancer patient care and patented a concept merging genetics with bioengineering (UK patent GB20110021917).After joining Queen Mary University, the progression was from Senior Research Fellow to Reader by 2022. The primary research focus is on DNA methylation biomarkers for cancer diagnosis and prognosis. Notable achievements include improved methods for papillomavirusinfected women triage and the development of a prostate cancer management classifier. Future endeavors aim at early epithelial cancer detection and refining biomarkers across ethnicities.
Session Abstract – PMWC 2024 Silicon Valley
Track Chair: Laura J. van 't Veer, UCSF
- PMWC 2024 Award Ceremony
Pioneer Honoree: David Sidransky, Johns Hopkins
Luminary Honorees: Helmy Eltoukhy & AmirAli Talasaz, Guardant Health - Utilities of Liquid Biopsy in Biomarker Testing
- Laura Vent Veer, UCSF - Status Quo of Clinical Liquid Biopsy
Chair: Helmy Eltoukhy, Guardant Health
- Sadakatsu Ikeda, Tokyo Medical University
- Heather Parsons, Dana-Farber Cancer Institute
- Bruna Pellini, Moffitt Cancer Center
- Sanjay Popat, The Royal Marsden - Liquid Biopsy for Health Monitoring and Disease Prevention (PANEL)
Chair: Anne-Renee Hartman, Adela Bio
- AmirAli Talasaz, Guardant Health
- Heather Parsons, Dana-Farber Cancer Institute
- Mary Pat Lancelotta, Adaptive Bio - Liquid Biopsy in Early Cancer Detection (PANEL)
Chair: Tom Beer, Exact Sciences
- Wendy Rubinstein, Cancer Screening Research Network (CSRN) - Keynote: Pioneering Liquid Nucleic acids Tumor Fragments in Health and Diseases
- David Sidransky, Johns Hopkins - New Approaches in Liquid Biopsy (PANEL)
Chair: Victor Velculescu, Johns Hopkins
- David Sidransky, Johns Hopkins
- Dan Laudau, NY Genome Center
- Daniel De Carvalho, University of Toronto - Global Implications: A scalable Liquid Biopsy for HPV-related Cervical Cancer (PANEL)
Chair: Debra Fraser-Howze, D. Fraser Associates
- Belinda Nedjai, Wolfson Institute of Population Health
- Elisabeth Adams, Aquarius Population Health Limited - PMWC Showcase
- Sandrine Miller-Montgomery, Micronoma
